Kodu・Aktsiate loetelu・Haemonetics Corp

Haemonetics Corp

Avatud

SektorTervishoid

107.87 -0.39

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

106.69

Max

108.62

Põhinäitajad
By Trading Economics
Sissetulek	53M 33M
Müük	-7M 339M
P/E Sektori keskmine	43.82 57.371
Aktsiakasum	1.14
Kasumimarginaal	9.727
Töötajad	3,009
EBITDA	70M 75M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	-5.55% downside

Dividendid
By Acuity
Järgmine tulemuste avaldamine	5. nov 2026

Turustatistika
By TradingEconomics
Turukapital	163M 4.1B
Eelmine avamishind	108.26
Eelmine sulgemishind	107.87

Uudiste sentiment

By Acuity

100%

326 / 340 Pingereas Healthcare

Haemonetics Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. aug 2026, 19:46 UTC

Haemonetics Corp shares are lower today amid rising oil prices and geopolitical tensions. The stock rebounded earlier but has since declined in routine fluctuations.

21. aug 2026, 23:01 UTC

Haemonetics Corp is modestly higher in after-market trading, maintaining strength above its 20-day moving average and nearing the upper end of its one-month range.

20. aug 2026, 23:01 UTC

Haemonetics Corp shares are higher in after-market hours, nearing the top of their one-month trading range and above the 20-day moving average.

19. aug 2026, 23:41 UTC

Haemonetics Corp shares declined after-market, retracing from earlier gains. The asset remains above its 20-day moving average and near the upper end of its one-month range.

18. aug 2026, 23:42 UTC

Haemonetics Corp shares are trading lower in after-market hours, reflecting a decline from earlier highs, though remaining above the 20-day moving average.

17. aug 2026, 20:06 UTC

Haemonetics Corp shares are lower today, reflecting broader market pressures amid a notable drop in U.S. retail sales for July.

14. aug 2026, 19:51 UTC

Haemonetics Corp shares are higher today, supported by a positive trend in the Health Care Supplies sector and increased trading volume.

13. aug 2026, 19:51 UTC

Haemonetics shares are declining amid rising jobless claims and flat Producer Price Index data, breaking a recent trend of higher daily closes.

12. aug 2026, 20:01 UTC

Haemonetics Corp shares are higher today, supported by unusually high trading volume and a strong upward trajectory since Tuesday's close.

11. aug 2026, 20:06 UTC

Haemonetics Corp shares are higher today, maintaining a position near the upper end of their one-month range despite a minor pullback earlier in the session.

10. aug 2026, 19:46 UTC

Haemonetics Corp shares are declining amid broader market uncertainty following recent U.S. employment data, despite earlier gains during the session.

7. aug 2026, 22:01 UTC

News

Haemonetics shares are lower in after-market trading despite Citigroup raising its price target to $92 and maintaining a Neutral rating.

6. aug 2026, 21:01 UTC

Haemonetics Corp. shares are trading higher in after-market hours, remaining above the 20-day moving average and near the upper end of their one-month range.

5. aug 2026, 19:31 UTC

Haemonetics Corp shares are lower today, breaking a trend of higher closes. The stock is experiencing unusually high trading volume amid no specific news.

4. aug 2026, 21:01 UTC

Haemonetics Corp shares declined in after-market hours, despite broader market gains from positive U.S.-Iran negotiations and falling crude oil prices.

3. aug 2026, 19:56 UTC

Haemonetics Corp shares are higher, reflecting broader market gains amid positive momentum in major tech stocks and easing geopolitical tensions.

31. juuli 2026, 20:04 UTC

Haemonetics Corp shares are higher, with no specific news identified. The broader market has also gained since Thursday's close, recovering from earlier losses.

30. juuli 2026, 19:48 UTC

Haemonetics Corp. shares are lower today, continuing a decline since Wednesday. The stock remains above its 20-day moving average despite recent downward movement.

29. juuli 2026, 21:21 UTC

Haemonetics Corp shares are lower in after-market trading, reflecting broader declines in the equity market and Health Care Supplies sector amid rising oil prices.

28. juuli 2026, 21:01 UTC

Haemonetics Corp shares are lower in after-market hours, following a broader market decline amid a significant drop in the Nikkei 225 Index.

27. juuli 2026, 22:51 UTC

Haemonetics Corp shares are higher in after-market trading, supported by falling crude oil prices and strong performance above the 20-day moving average.

24. juuli 2026, 20:31 UTC

Haemonetics Corp shares are lower in after-market hours, continuing a decline from Friday's close. No specific news was identified to explain the movement.

23. juuli 2026, 23:21 UTC

Haemonetics Corp shares are lower in after-market trading, continuing a decline that began after Thursday's close, reaching the midpoint of their one-month trading range.

22. juuli 2026, 20:13 UTC

Shares of Haemonetics Corp are trading higher in after-market hours, positioned above its 20-day moving average amid broader market volatility and rising crude oil prices.

20. juuli 2026, 18:46 UTC

Haemonetics Corp shares are higher today, continuing gains since Friday's close. The stock reached a session high earlier, though it has pulled back.

Võrdlus sarnastega

Hinnamuutus

Haemonetics Corp Prognoos

Hinnasiht

By TipRanks

-5.55% langus

12 kuu keskmine prognoos

Keskmine 102.38 USD -5.55%

Kõrge 120 USD

Madal 84 USD

Põhineb 9 Wall Streeti analüütiku instrumendi Haemonetics Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

9 ratings

Osta

Hoia

Müü

Põhineb 9 analüütiku instrumendi Haemonetics Corp aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

326 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Haemonetics Corp

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.